Diagnostic characterization of a feral swine herd enzootically infected with Brucella.
Eighty feral swine were trapped from a herd that had been documented to be seropositive for Brucella and which had been used for Brucella abortus RB51 vaccine trials on a 7,100-hectare tract of land in South Carolina. The animals were euthanized and complete necropsies were performed. Samples were taken for histopathology, Brucella culture, and Brucella serology. Brucella was cultured from 62 (77.5%) animals. Brucella suis was isolated from 55 animals (68.8%), and all isolates were biovar 1. Brucella abortus was isolated from 28 animals (35.0%), and isolates included field strain biovar 1 (21 animals; 26.3%), vaccine strain Brucella abortus S19 (8 animals, 10.0%), and vaccine strain Brucella abortus RB51 (6 animals, 7.5%). Males were significantly more likely to be culture positive than females (92.9% vs. 60.6%). Thirty-nine animals (48.8%) were seropositive. Males also had a significantly higher seropositivity rate than females (61.9% vs. 34.2%). The relative sensitivity rates were significantly higher for the standard tube test (44.6%) and fluorescence polarization assay (42.6%) than the card agglutination test (13.1%). Lesions consistent with Brucella infection were commonly found in the animals surveyed and included inflammatory lesions of the lymph nodes, liver, kidney, and male reproductive organs, which ranged from lymphoplasmacytic to pyogranulomatous with necrosis. This is the first report of an apparent enzootic Brucella abortus infection in a feral swine herd suggesting that feral swine may serve as a reservoir of infection for Brucella abortus as well as Brucella suis for domestic livestock.
Stoffregen
William C
WC
Bacterial Diseases of Livestock Research Unit, National Animal Disease Center, US Department of Agriculture, Ames, IA 50010, USA. bstoffre@nadc.ars.usda.gov
Olsen
Steven C
SC
Jack Wheeler
C
C
Bricker
Betsy J
BJ
Palmer
Mitchell V
MV
Jensen
Allen E
AE
Halling
Shirley M
SM
Alt
David P
DP
D000372:Agglutination Tests / Q000662:veterinary; D000818:Animals; D000835:Animals, Wild; D000907:Antibodies, Bacterial / Q000097:blood; D002002:Brucella / Q000235:genetics / Q000302:isolation & purification*; D002006:Brucellosis / Q000097:blood / Q000453:epidemiology / Q000473:pathology / Q000662:veterinary*; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D005260:Female; D016231:Fluorescence Polarization Immunoassay / Q000662:veterinary; D006651:Histocytochemistry / Q000662:veterinary; D008297:Male; D018598:Minisatellite Repeats / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000662:veterinary; D017422:Sequence Analysis, DNA; D016036:Seroepidemiologic Studies; D013022:South Carolina / Q000453:epidemiology; D013552:Swine; D013553:Swine Diseases / Q000097:blood / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology; D015047:Zoonoses / Q000382:microbiology
D000907:Antibodies, Bacterial; D004269:DNA, Bacterial